Search research articles
Contact Us
Filters
Showing results (71-80 of 211) with videos related to
Page
of 22
Sort By:
American Journal of Obstetrics and Gynecology
|
June 21, 2020
Reengineering academic departments of obstetrics and gynecology to operate in a pandemic world and beyond: a joint American Gynecological and Obstetrical Society and Council of University Chairs of Obstetrics and Gynecology statement
Ronald D Alvarez, Barbara A Goff, David Chelmow, et al.
Gynecologic Oncology
|
December 9, 2015
Phase 1b safety study of farletuzumab, carboplatin and pegylated liposomal doxorubicin in patients with platinum-sensitive epithelial ovarian cancer
Kenneth H Kim, Danijela Jelovac, Deborah K Armstrong, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 26, 2012
The effect of the APPRISE mandate on use of erythropoiesis-stimulating agents and transfusion rates in patients with ovarian cancer receiving chemotherapy
Jonathan D Boone, Janelle M Fauci, Christy L Walters, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 28, 2003
Phase III randomized trial of 12 versus 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: a Southwest Oncology Group and Gynecologic Oncology Group trial
Maurie Markman, P Y Liu, Sharon Wilczynski, et al.
Gynecologic Oncology
|
February 10, 2009
An outpatient intraperitoneal chemotherapy regimen for advanced ovarian cancer
Emily Berry, Kellie S Matthews, Diljeet K Singh, et al.
Gynecologic Oncology
|
November 8, 2005
Anti-tumor activity of TRA-8 anti-death receptor 5 (DR5) monoclonal antibody in combination with chemotherapy and radiation therapy in a cervical cancer model
J Michael Straughn, Patsy G Oliver, Tong Zhou, et al.
American Journal of Obstetrics and Gynecology
|
March 3, 2023
Reimagining the Council of University Chairs of Obstetrics and Gynecology in evolving times
Ronald D Alvarez, David Chelmow, Donna D Johnson, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
January 21, 2012
A dietary pattern associated with LINE-1 methylation alters the risk of developing cervical intraepithelial neoplasia
Chandrika J Piyathilake, Suguna Badiga, Edmond K Kabagambe, et al.
Expert Opinion on Investigational Drugs
|
February 26, 2026
Potential of IMNN-001 in epithelial ovarian cancer: assessment of clinical findings
Premal H Thaker, Stacy R Lindborg, Ana Limon, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 8, 2015
Does a standardized preoperative algorithm of clinical data improve outcomes in patients with ovarian cancer? A quality improvement project
Monjri M Shah, Charles A Leath, Laura Rebecca Daily, et al.
Page
of 22
Search research articles
Search
Showing results (71-80 of 211) with videos related to
Sort By:
Page
of 22
American Journal of Obstetrics and Gynecology
|
June 21, 2020
Reengineering academic departments of obstetrics and gynecology to operate in a pandemic world and beyond: a joint American Gynecological and Obstetrical Society and Council of University Chairs of Obstetrics and Gynecology statement
Ronald D Alvarez, Barbara A Goff, David Chelmow, et al.
Gynecologic Oncology
|
December 9, 2015
Phase 1b safety study of farletuzumab, carboplatin and pegylated liposomal doxorubicin in patients with platinum-sensitive epithelial ovarian cancer
Kenneth H Kim, Danijela Jelovac, Deborah K Armstrong, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 26, 2012
The effect of the APPRISE mandate on use of erythropoiesis-stimulating agents and transfusion rates in patients with ovarian cancer receiving chemotherapy
Jonathan D Boone, Janelle M Fauci, Christy L Walters, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 28, 2003
Phase III randomized trial of 12 versus 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: a Southwest Oncology Group and Gynecologic Oncology Group trial
Maurie Markman, P Y Liu, Sharon Wilczynski, et al.
Gynecologic Oncology
|
February 10, 2009
An outpatient intraperitoneal chemotherapy regimen for advanced ovarian cancer
Emily Berry, Kellie S Matthews, Diljeet K Singh, et al.
Gynecologic Oncology
|
November 8, 2005
Anti-tumor activity of TRA-8 anti-death receptor 5 (DR5) monoclonal antibody in combination with chemotherapy and radiation therapy in a cervical cancer model
J Michael Straughn, Patsy G Oliver, Tong Zhou, et al.
American Journal of Obstetrics and Gynecology
|
March 3, 2023
Reimagining the Council of University Chairs of Obstetrics and Gynecology in evolving times
Ronald D Alvarez, David Chelmow, Donna D Johnson, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
January 21, 2012
A dietary pattern associated with LINE-1 methylation alters the risk of developing cervical intraepithelial neoplasia
Chandrika J Piyathilake, Suguna Badiga, Edmond K Kabagambe, et al.
Expert Opinion on Investigational Drugs
|
February 26, 2026
Potential of IMNN-001 in epithelial ovarian cancer: assessment of clinical findings
Premal H Thaker, Stacy R Lindborg, Ana Limon, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 8, 2015
Does a standardized preoperative algorithm of clinical data improve outcomes in patients with ovarian cancer? A quality improvement project
Monjri M Shah, Charles A Leath, Laura Rebecca Daily, et al.
Page
of 22